MedTrace Logo

Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate

NCT00459407 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2014-10-08

No results posted yet for this study

Summary

Green tea extract contains ingredients that may prevent or slow the growth of prostate cancer. This phase I trial is studying how well green tea extract works in treating patients with prostate cancer undergoing surgery to remove the prostate

Conditions

  • Adenocarcinoma of the Prostate
  • Stage I Prostate Cancer
  • Stage II Prostate Cancer

Interventions

DIETARY_SUPPLEMENT

defined green tea catechin extract

Given orally

DRUG

placebo

Given orally

OTHER

immunohistochemistry staining method

Correlative studies

OTHER

immunoenzyme technique

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

PROCEDURE

biopsy

Undergo biopsy

OTHER

mass spectrometry

Correlative studies

OTHER

high performance liquid chromatography

Correlative studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    lead NIH

Principal Investigators

  • Frederick Ahmann · Arizona Cancer Center - Tucson

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00459407 on ClinicalTrials.gov